As if the world didn’t have enough to worry about, Europe is now facing a surge in the A(H3N2) subclade K flu strain, which is taking over faster than a viral TikTok dance. First spotted in Norway and then the UK, this strain is now a global sensation—detected in over 34 countries and accounting for a staggering 90% of confirmed influenza cases in the WHO European Region. Talk about a party crasher!
Emerging from the J.2.4 viruses, subclade K has waltzed its way into nearly half of all A(H3N2) sequences in the EU/EEA since May 2025. It’s like that one friend who shows up uninvited and takes over the conversation.
The flu season kicked off way earlier this year, stretching the typical timeline by weeks. By week 49, Europe was in full swing with respiratory illnesses, leaving healthcare systems gasping for breath. Notably, influenza causes up to 50 million symptomatic cases annually in Europe, adding further strain to the already burdened healthcare system. In fact, vaccination remains the best defense against severe outcomes from this virus.
Now, here’s the kicker: while hospitalizations are up, especially among those aged 65 and older, there’s no evidence that this strain is packing a bigger punch than its predecessors. So, is it a fierce foe or just an annoying nuisance? The jury’s still out.
But hold on—let’s talk vaccines. There’s a significant mismatch between the circulating strain and the vaccine. Yep, you heard that right. The current vaccines might not be as effective as hoped, particularly against severe cases.
Real-world data is scarce, but early estimates show only about 32-39% effectiveness in adults. For kids, it’s a little better, hovering around 72-75%.
In a nutshell, subclade K is here, and it’s making waves. The flu season may feel intense, but for now, it doesn’t seem to be the villain it could have been.
Still, with its rapid spread and vaccine mismatch, Europe’s got its work cut out for it. Buckle up, folks.
